Read until the end........ Wow!

houstonchronicle.com/opinion/outloo…

Opinion: Warp Speed to a united or divided America? COVID-19 vaccine trials must include at-risk groups - HoustonChronicle.com houstonchronicle.com/opinion/outloo…

Novavax slide on neutralizing antibody levels of #COVID19 vaccine candidate vs human convalescent plasma, from phase 1 trial

Hey NBC. The antibodies in your report graphic on anti sera treatment are binding the wrong way!

Indeed a voice of reason

Certainly encouraging!

US: Nearly a fifth of enrollees in Pfizer, BioNTech Covid-19 vaccine study are Black or Latino - Times of India timesofindia.indiatimes.com/world/us/us-ne…

University of Oxford 2/ Profiling women at Oxford Uni contributing great science to tackle COVID. #2: Teresa Lambe -Senior scientist. Helped design the Oxford ChAdOx1 nCoV-19 vaccine and oversaw pre-clinical assessment showing high Ab titres and neutralisation. pubmed.ncbi.nlm.nih.gov/32793398/ #WomenInSTEM

We are delighted to be a #blueknight company, and are grateful for the COVID19 developmental guidance from BARDA and Janssen. #7HP349, #jlabs@tmc, #geriatrics, #COVID19vaccine

13/13 12. Business as usual is not working. The White House + HHS agencies need to communicate to the American people and not speak to us like we're in 4th grade. We need a full FDA review, even expedited, even using EAPs, or if not we must demand a full accounting/explanation

Beautiful work

I wish Melania and Donald Trump a speedy recovery. Nobody deserves to get infected with SARS-CoV-2 and we should do all we can to stop the spread of this virus.

Anthony S. Fauci, M.D. • Samuel J. Heyman Service to America Medals servicetoamericamedals.org/honorees/antho…

We dosed our first set of human subjects with 7HP349 last week!!! biospace.com/article/releas…

What if we could improve immune response to vaccines in at-risk patients? Meet Upendra Marathi, President & CEO of Upendra, a #JLABSTMC & #BLUEKNIGHT company working with the aim to improve global public health: bit.ly/2UNkL8j #BeyondtheBiotech

Prof Peter Hotez MD PhD DSc(hon) Texas Children's Boston Children's Precision Vaccines Program Science Translational Medicine Fascinating stuff!

Maria Bottazzi and Peter Hotez recognized for the Best Academic Research Award for their work in developing Carbevax, a COVID19 that has protected over 24 million kids in low and middle income countries.